Funding for this research was provided by:
National Institute for Health Research (RP-PG-1211-20012)
Received: 11 October 2017
Accepted: 6 February 2018
First Online: 22 February 2018
Ethics approval and consent to participate
: This survey was completed voluntarily by respondents from the British Association of Stroke Physicians (BASP) and the British Society of Neuroradiologists (BSNR) and did not include any sensitive topics. Based on the NHS Health Research Authority decision tools [CitationRef removed], approval by a Local Research Ethics Committee was not required. Informed consent was also not sought for the present study because responses to the Delphi and ranking exercises received by the research team were voluntary and completely anonymous. This approach was based upon local University advice/guidelines.
: Not applicable.
: PW is co-PI for 2 randomised thrombectomy trials (PISTE & STABILISE) in acute stroke. Start-up phase of PISTE was mainly funded by the Stroke Association but was also part-funded by unrestricted educational grants from Covidien & Codman who manufacture stroke thrombectomy devices. STABILISE is part-funded by Microvention. PW has undertaken educational consultancy work for Stryker & Microvention who both manufacture stroke thrombectomy devices.GAF is co-PI for STABILISE. GAF’s previous institution received research grants from Boehringer Ingelheim (manufacturer of Alteplase), and honoraria from Lundbeck for stroke-related activities. GAF has received personal remuneration for educational/advisory work from Boehringer Ingelheim and Lundbeck. GAF is supported by an NIHR Senior Investigator award.DF, GAF and PM have been involved in marketing for a Computerised Decision Aid for Stroke Thrombolysis, which may be made available for a cost to purchase the decision aid.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.